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Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929.
Peritoneal dialysis (PD) fluids are known to suppress the reactions of
inflammatory cells in vitro. PD-fluids have also been shown to have
cytotoxic influence on mesothelial cells. The combinations of these
factors may have a detrimental effect on the peritoneum or may impair
cellular defence against bacterial peritonitis. Some authors have dis-
cussed the relevance of heat sterilization to both so-called peritoneal
side-effects and to chemical decomposition of fluids. Four commercial
PD-fluids and one laboratory-made PD-fluid were tested for cytotoxic-
ity on a cultured fibroblast cell line, L-929. Cytotoxicity was determined
as an inhibition of cell growth by quantification of total protein. The
laboratory-made PD-fluid was sterilized either by filtration or by
filtration and heat. The commercial and the heat-sterilized laboratory
made PD-fluids caused significant inhibition of cell growth (53 to 76%)
in contrast to saline and the filter-sterilized laboratory-made PD-fluid.
Since the pH values of all the testsolutions were neutral, low pH was
not the cause of toxicity. Our results regarding the L-929 cells indicate
that the cytotoxicity of PD-fluids is of a general nature. Furthermore,
the results indicate that the heat sterilization process might be partially
responsible for causing toxicity in PD-fluids.
Continuous ambulatory peritoneal dialysis (CAPD) was de-
veloped as an alternative treatment for end-stage renal disease
[1]. The PD-fluids used in CAPD treatment have been assumed
to be nontoxic in biological systems. As a consequence, minor
attention has been paid to the chemically induced toxicity of
these fluids. Instead, research has mainly focused on the
adverse effects related to low pH and high osmolarity. Recently
it was shown by Bronswijk et al [21 that PD-fluids can have a
cytotoxic influence on human mesothelial cells in vitro. Neither
p11 exclusively, nor high glucose concentration, was suggested
as the cause of the cytotoxicity found in that study. Further-
more, Topley et al [3] have suggested that PD-fluids with low
pH may contain substances that inhibit inflammatory cells.
Attention has also been drawn, by Henderson [4] to the fact that
PD-fluids could contain potentially harmful components as well
as toxic contaminants. It was also pointed out that heat steril-
ization might induce decomposition and degradation of PD-
fluids.
Since patients are treated several times daily and over many
years, we believe that it would be of interest to test PD-fluids
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for general cytotoxicity. As a target for this general cytotoxicity
we chose cultured fibroblasts, L-929, as many basic mecha-
nisms are similar in both specialized and non-specialized cell
types. Thus, the aim of this study was to investigate the general
cytotoxicity of commercially available PD-fluids on a cultured
fibroblast cell line and also relate this toxicity to the sterilization
procedure.
Methods
A mouse fibroblast cell line L-929 was grown as a monolayer
in Eagle's Minimum Essential Medium (MEM; Biological In-
dustries, Israel) containing nonessential aminoacids (1%), sup-
plemented with 10% fetal calf serum, 50 pg/ml gentamycin and
2 mst L-glutamine (Nordvacc, Sweden and Biological Indus-
tries, Israel). The cultures were subcultivated twice a week
using 0.1% trypsin (Nordvacc, Sweden) in Ca2- Mg2-free
phosphate buffered solution. The cultures were maintained at
37°C in humidified air with 5% CO2. The tests were performed
in 96-well tissue culture plates (Greiner, Germany and Bibby,
England, UK), with 200 p1 solution per well. L-929 cells were
taken from a subconfluent culture, and inoculated in a 96-well
tissue culture plate at a density of 1900 cells/cm2. Twenty-four
hours after inoculation, the growth medium was removed and
200 p1 of each test solution and control (only MEM) was added
to eight parallel wells. Three days later (during exponential
growth), total protein was determined by an assay based on
Commassie brilliant blue (Bio Rad, Richmond, California,
USA) [5]. The photometric absorbance was measured at 630 nm
with 410 nm as a reference wavelength using a Dynatech MR
700 photometer (UK).
Four different brands of commercially available PD-fluids,
(one bag each) and two concentrations of sodium chloride (0.9%
and 1.2%) were tested (Table 1). Since this study was intended
for investigation and not for marketing we have chosen to use
numbers (1 to 4) instead of brand names. For information the
fluids (in random order) were: Gambrosol (Gambro AB), Pen-
tolys (ACO), Lockolys (Fresenius) and Dianeal (Baxter).
To be able to evaluate the influence of the sterilization
process we produced a PD-fluid in our laboratory that had the
following composition (see Gambrosol): D-glucose 15 g (BDH
Limited Poole), DL-sodium lactate (50%) 9 g (Merck), sodium
chloride 5.4 g (Merck), calcium chloride anhydrous 190 mg
(Merck) and magnesium chloride hexahydrate 51 mg (Merck).
The pH was adjusted to 5.5 with hydrochloric acid and then
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deionized water was added to give a final volume of 1000 ml.
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Table 1. The PD-fluids (1—4, of four different commercial brands)
used in the study
Fluids % Glucose
Osmotic
pressure
1
2
3
4
1.36
1.36
1.50
1.50
340 mOsmlkg
350 mOsm/liter
358 mOsm/liter
370 mOsm/liter
NaC1 0.9%
NaC1 1.2%
—
—
290 mOsm/liter
390 mOsm/liter
Eagle's MEM 0.1 330 mOsmlliter
All values are according to the respective manufacturer or reference
[15], except NaC1 (calculated). One bag of each brand was tested prior
to date of expiration. The numbered PD-fluids are the same as in Table
2.
The test solutions were diluted 1 + 1 in Eagle's MEM. Fetal calf
serum was added to a final concentration of 10%. This proce-
dure resulted in a pH range of 7.3 to 7.6 in all solutions. The
commercially available PD-fluids had been heat-sterilized by
the manufacturer. The laboratory-made PD-fluid was first ster-
ilized by filtration (0.22 pm Sterivex-GS Millipore) and then
tested for cytotoxicity both before and after further sterilization
by heat (1 hr at 121°C).
Inhibition of cell growth was calculated as the relative
difference between control wells and test wells and determined
on 5 to 12 separate occasions. The results are presented as
mean SEM. All the statistics were performed using Kruscal-
Wallis and Fischer (ANOVA) test.
Results
The results are shown in Table 2. No differences in cell
growth were observed between isoosmotic saline (0.9%) and
hyperosmotic saline (1.2%). On the other hand, all the commer-
cial PD-fluids significantly inhibited cell growth when compared
to 0.9% saline (P < 0.001). Inhibition of cell growth caused by
the filter-sterilized, laboratory-made, PD-fluid was considerably
lower (26 4%) than for the corresponding heat-sterilized
PD-fluid (76 5%). Only a minor, but significant, difference
was seen between saline (0.9%) and the filter-sterilized labora-
tory-made, PD-fluid.
Discussion
Glucose is known to spontaneously decompose in various
intermediates, for instance 5-hydroxymethylfurfural, formic-
and laevulinic acids. Furthermore, it has been suggested that
the accumulation of glucose decomposition products may play
a significant role in causing hypertonic infusion pain and that
the degree of decomposition is related to both heat treatment
and the age of the PD-fluid [4, 6]. However, all these degrada-
tion products have so far been assumed to be nontoxic. The
L-929 continuous fibroblast cell line, has been used for screen-
ing toxicity of both chemical and biomatenals. Analysis of total
protein is a well characterized and reproducible method and
may be used to determine cell growth as we have done in our
experiments [5, 7]. Inhibition of cell growth does not necessar-
ily imply injury to the cells but is generally regarded as a
predictive tool foi- assessing toxicity. The correlation to toxicity
in vivo is good [8, 91. Some reports also demonstrate that
Table 2. Inhibition of cell growth on cultured fibroblasts after
exposure to PD-fluid or saline
% Inhibition Test
Test solution of cell growth occasions
NaCI 0.9% 15 5 12
NaCI 1.2% 22 4 NS 5
PD-fluid I 53 2 5
PD-fluid 2 66 4 5
PD-fluid 3 63 4 5
PD-fluid 4 75 3a 5
PD-fluid (lab.made, filtered) 26 4" 7
PD-fluid (lab.made, filter- 76 3 7
and heat-sterilized)
The test solutions were all diluted I + I in Eagle's MEM medium.
Values are given as mean SEM. All statistical comparisons are made
versus NaCI 0.9%. The numbered PD-fluids are the same as in Table 1.
NS, not significant.
a P < 0.001
b P < 0.05
toxicity ranking of chemicals is almost the same regardless of
cellular types [10, 11]. This is probably due to the fact that many
basic cellular mechanisms are similar in both specialized and
nonspecialized cells. Thus, the toxicity observed in our exper-
iments is most probably of a general nature. Cytotoxicity of
PD-fluids on human mesothelial cells in vitro [2] is in compli-
ance with the toxicity on the cell line L-929 underlying the
applicability of the extrapolation towards mesothelial cells.
It has been demonstrated that PD-fluids may suppress the
production of superoxide anion from human neutrophils, inhibit
TNF (tumour necrosis factor), release from leukocytes and
reduce oxygen uptake and chemiluminiscence from peritoneal
phagocytes [3, 12, 13]. This failure of peritoneal cells to react
upon an inflammatory stimulus in the presence of PD-fluid
might influence the cellular defence against bacterial infections.
As some inflammatory cells in vitro regain their functions when
the pH is neutralized [3], a possible explanation for the failure
of the cells in peritoneum to react might be the low pH of the
PD-fluid. In contrast, in vitro pretreatment of peripheral poiy-
morphonuclear leukocytes (PMN) with an acidic buffer at pH
5.3 did not suppress cellular responses [3], and acidic culture
medium (pH 5.5) was not toxic on mesothelial cells [2]. From
experiments in vivo, PD-fluids are known to be almost neutral-
ized within a few minutes [14]. During these minutes, however,
the low pH of the fluids may affect the pentoneum. Since all our
test fluids were pH-neutral we do not interpret pH as being the
cause for the cytotoxicity revealed in our study. To pinpoint the
influence of osmolarity, the fibroblasts were exposed to a
hyperosmotic solution. As no difference in cell growth was
found, our results indicate a more general cytotoxicity of
commercial PD-fluids, rather than one dependent on pH or
osmolarity.
To study if biologically active substances are formed during
heat sterilization, we made a PD-fluid in the laboratory. The
sterile-filtered PD-fluid did not affect cell growth while the
heat-sterilized fluid did. This indicates that the in vitro cytotox-
icity of the commercial PD-fluids might be related to the
sterilization procedure. In contrast, Topley et a! [3] reported no
differences in their in vitro system with PMN exposed to filtered
or heat-treated PD-fluids. Perhaps the short exposure period of
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the cells (less than 1 hr) used in their experiments does not
reveal the cytotoxicity we demonstrated with 72 hours expo-
sure using the fibroblast cell line. It is important to remember
that in the clinical situation the patients are treated for much
longer periods, with fluids renewed several times daily.
We conclude that the commercially available PD-fluids
tested, regardless of brand, act cytotoxically on cultured fibro-
blasts. The toxicity might be related to the decomposition of the
PD-fluids due to heat sterilization.
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